Status:
TERMINATED
Ultrasound of the Thoracolumbar Fascia for Diagnosing Chronic Low Back Pain
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsors:
Fonds de la Recherche en Santé du Québec
Conditions:
Low Back Pain
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
It is estimated that 23% of Quebecers suffer from chronic low back pain, and that 12% are disabled by this condition. Despite medical advances, the origin of so-called 'nonspecific low back pain' rema...
Detailed Description
This will be a phase II, prospective, randomized controlled study, which will have received IRB approval and will be registered at Clinicaltrials.gov before it begins. Participants with chronic non sp...
Eligibility Criteria
Inclusion
- Ongoing low back and/or referred pain (non-specific pattern) above or just below the gluteal fold of at least 3/10 on a numerical pain rating scale (NRS), for at least 3 months;
- Pain has resulted in a problem on at least 50% of the days in the past 6 months;
- Only use of oral non-steroidal anti-inflammatory drugs for pain treatment in the 4 weeks before treatment;
- Willingness to commit to treatment sessions (acupuncture, chiropractic therapy or therapeutic massage) and to follow-up visits.
Exclusion
- Back pain attributable to a specific, recognizable, known pathology:
- protrusion or prolapse of 1 or more intervertebral discs with concurrent neurological symptoms;
- radicular pain (sciatica);
- infectious spondylopathy;
- low back pain caused by inflammatory, malignant, or autoimmune disease;
- congenital deformation of the spine (except for slight lordosis or scoliosis);
- compression fracture caused by osteoporosis;
- spinal stenosis;
- spondylolysis or spondylolisthesis;
- Pregnancy;
- History of spinal surgery;
- History of pelvis or hip fractures;
- Acupuncture, spinal manipulation or therapeutic massage for back pain within the past year;
- Severe clotting disorders or anticoagulant therapy;
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 24 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04843800
Start Date
November 1 2022
End Date
July 24 2024
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2X 0C1